Biovision
Human CellExp™ CD33/SIGLEC-3
- SKU:
- 26-P1616
- Availability:
- Usually Shipped in 5 Working Days
- Storage Temperature:
- -20ºC
- Shipping Conditions:
- Gel Pack
- Shelf Life:
- 12 months
Description
Biomolecule/Target: N/A
Synonyms: gp67; Siglec-3; CD33; Sialic acid binding Ig-like lectin 3; Myeloid cell surface antigen CD33
Alternates names: gp67; Siglec-3; CD33; Sialic acid binding Ig-like lectin 3; Myeloid cell surface antigen CD33
Taglines: Human recombinant with Fc & His Tag
Taglines: USA
Country of Animal Origin: N/A
NCBI Gene ID #.: 945
NCBI Gene Symbol: N/A
Gene Source: Human
Accession #: P20138; NP_001763.3
Recombinant: TRUE
Source: HEK293 cells
Purity by SDS-PAGE #: ≥ 97% by SDSPAGE
Assay: N/A
Purity: N/A
Assay #2: N/A
Endotoxin Level: < 0.1 EU/μg of the protein as determined by LAL method.
Activity (Specifications/test method): N/A
Biological activity: The activity was measured by the binding ability in a functional ELISA. Immobilized Human CD33 at 2 μg/ml (100 μl/well) can bind Anti-Human CD33 Antibody in the linear range of 8-20 ng/ml.
Results: N/A
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: The protein migrates as a band at 70 kDa (Fc and 6×His tag at the C-terminus).
Concentration: N/A
Appearance: Lyophilized protein
Physical form description: N/A
Reconstitution Instructions: Reconstitute to a concentration of 0.1-0.5 mg/ml in sterile distilled water.
Background Information: CD33 is a member of the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. This single-pass type I membrane protein contains one Ig-like C2-type (immunoglobulin-like) domain and one Ig-like Vtype (immunoglobulin-like) domain. It is considered myeloid-specific, but it can also be found on some lymphoid cells. It binds to α2-6- and α2-3-sialylated glycans and sialylated ligands. It acts as an inhibitory receptor since, when it is crosslinked, it becomes phosphorylated on its cytoplasmic ITIM sequence that recruits SHP-1 and SHP-2 phosphatases and negatively regulates cell activation in both myeloid cell lines and activated NK cells. It induces apoptosis in acute myeloid leukemia and is a target for the treatment of leukemia.
Amino acid sequence: aa Asp18-His259 of human protein. The target protein is expressed with the sequence (Asp18-His259) of human CD33/Siglec-3 fused with an Fc and 6×His tag at the C terminus.
Handling: Centrifuge the vial prior to opening.
Usage: For Research Use Only! Not to be used in humans